@article{125bff59c88e4f68b6d142527ea7255a,
title = "Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic",
author = "Pavel Jansa and David Ambro{\v z} and Maty{\'a}{\v s} Kuhn and Vladim{\'i}r Dytrych and Michael Aschermann and Vladim{\'i}r {\v C}ern{\'y} and Virginie Gressin and Samuel Heller and Jan Kunst{\'y}{\v r} and Michal {\v S}iranec and Ci Song and Ale{\v s} Linhart and Jaroslav Lindner and Audrey Muller",
note = "Funding Information: Medical writing and editorial support for the development of this manuscript, under the direction of the authors, were provided by Carrie Fielden, MSc, Malgorzata Urbacz, MSc, and Rosalind Perrett, BA, of Ashfield MedComms, an Ashfield Health company, and was funded by Actelion Pharmaceuticals Ltd., Allschwil, Switzerland, a Janssen Pharmaceutical company of Johnson and Johnson. Funding Information: Pavel Jansa has received fees and grants from Janssen Pharmaceutical Companies of Johnson and Johnson, AOP Orphan, and MSD. Audrey Muller and Virginie Gressin are employees of, and have shares in Janssen, a pharmaceutical company of Johnson and Johnson. Ci Song was an employee of Janssen, a pharmaceutical company of Johnson and Johnson, at the time of data collection and manuscript development. The remaining authors declare that there are no conflict of interests. Publisher Copyright: {\textcopyright} 2022 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute.",
year = "2022",
month = jan,
doi = "10.1002/pul2.12038",
language = "English",
volume = "12",
journal = "Pulmonary Circulation",
issn = "2045-8932",
publisher = "SAGE Publications Inc.",
number = "1",
}